No Result
View All Result
  • Private Data
  • Membership options
  • Login
  • COUNTRY
    • ITALY
    • IBERIA
    • FRANCE
    • UK&IRELAND
    • BENELUX
    • DACH
    • SCANDINAVIA&BALTICS
  • PRIVATE EQUITY
  • VENTURE CAPITAL
  • PRIVATE DEBT
  • DISTRESSED ASSETS
  • REAL ESTATE
  • FINTECH
  • GREEN
  • PREMIUM
    • ItaHubHOT
      • ItaHub Legal
      • ItaHub Tax
      • ItaHub Trend
    • REPORT
    • INSIGHT VIEW
Subscribe
  • COUNTRY
    • ITALY
    • IBERIA
    • FRANCE
    • UK&IRELAND
    • BENELUX
    • DACH
    • SCANDINAVIA&BALTICS
  • PRIVATE EQUITY
  • VENTURE CAPITAL
  • PRIVATE DEBT
  • DISTRESSED ASSETS
  • REAL ESTATE
  • FINTECH
  • GREEN
  • PREMIUM
    • ItaHubHOT
      • ItaHub Legal
      • ItaHub Tax
      • ItaHub Trend
    • REPORT
    • INSIGHT VIEW
Home COUNTRY BENELUX

Glasgow-based ENOUGH bites €40 million growth funding to high-scale mycoprotein production

EU StartupsbyEU Startups
August 21, 2023
Reading Time: 4 mins read
in BENELUX, GREEN, UK&IRELAND, VENTURE CAPITAL
Share on FacebookShare on Twitter

ENOUGH, the food technology startup pioneering high-scale sustainable protein production, has raised €40 million in growth funding co-led by World Fund, one of Europe’s leading climate tech VC, and leading food tech investor CPT Capital which continued its commitment. Other previous investors, including AXA IM Alts through the Axa Impact Fund, HAL Investments through 280ppm, Onassis Group through Olympic Investments Inc, Tailored Solutions and Scottish Enterprise also followed on. 

Founded in 2015, with the mission to serve the world’s growing demand for sustainable protein, ENOUGH produces ABUNDA® mycoprotein, fermenting fungi using renewable feedstocks to produce alternative ingredient proteins at scale. This transformative ingredient will be used in alternative meat and dairy products sold in leading supermarkets and fast-food brands around the world through an array of partnerships, such as with M&S and Unilever.

Jim Laird, founder and CEO of ENOUGH, said: “ENOUGH has made great strides in the past few years to launch our new factory in the Netherlands and scale up to work with customers across the UK and Europe. With this new funding, we will accelerate that growth. The alternative protein market is a multi-billion dollar opportunity, and the ethical and environmental reasons to embrace non-animal protein sources are more pressing than ever. We’re delighted to be leading this food revolution with our proprietary ABUNDA mycoprotein. We’re excited to welcome our new investors World Fund and look forward to working closely with them on the next phase of growth for ENOUGH.” 

ENOUGH has developed a pioneering technology that enables large-scale sustainable protein production by creating a core protein ingredient to power alternative meat products across the world. Its signature mycoprotein is created by feeding fungi with sugars from sustainably sourced grain which is then fermented in a similar production to beer or wine. This creates ABUNDA, a food that is high in protein and fibre, contains all nine essential amino acids and crucially, boasts a neutral flavour and meat-like texture that can be used to create plant-based meat, fish and dairy products. ABUNDA is up to 15 times more efficient than protein from beef thanks to ENOUGH’s proprietary technology and zero-waste production – using up to 93% less water, 97% less feed and causing 97% fewer CO2 emissions than protein from beef, which also makes it more affordable to produce. 

ENOUGH recently opened a first-of-its-kind protein factory in Sas van Gent, Netherlands, to create ABUNDA at scale. The factory is co-located alongside a Cargill facility which ensures the most efficient feed source and supports the zero-waste strategy of ENOUGH’s product. Initially, the factory will produce 10,000 metric tonnes of ABUNDA per year, with plans to scale up to produce more than 60,000 tonnes per year – the equivalent of growing one cow’s worth of protein every two minutes. 

Craig Douglas, Founding Partner at World Fund, commented: “We’re delighted to be supporting ENOUGH as they scale up to become the global leader in sustainable protein. The company is tackling crucial bottlenecks in the creation of sustainable protein, whilst using fewer resources and maintaining a zero-waste process, which is enabling ENOUGH to have a lower carbon footprint compared to other plant-based protein sources, whilst producing at scale and providing supply security to a growing market. It helps that the products featuring ABUNDA are delicious too. ENOUGH’s work has the potential to help combat food scarcity, reduce the use of resources in the food industry and reduce emissions on a global scale and we look forward to working with Jim and the team to help them achieve this.” 

It is this efficient and scalable technology, combined with a zero-waste approach, that attracted Europe’s leading climate investor to back ENOUGH. World Fund backs entrepreneurs building climate technology solutions that have the potential to save significant amounts of CO2 every year.

Harry Kalms, CPT Capital, added: “We are excited to continue supporting the ENOUGH team to deliver high-quality, alternative protein solutions supporting change in the global food system. Since our first investment 5 years ago, ENOUGH has stood out as a company that is poised to make a meaningful positive impact on today’s unsustainable food system. Now, with the completion of their first industrial production facility and this growth financing round, ENOUGH is leveraging its strong foundations to move into a new phase of large-scale commercialisation.”

The new growth funding brings the total capital raised by ENOUGH to over €95 million. This will enable the company to scale up capacity at its factory in the Netherlands to serve growing customer demand for ABUNDA mycoprotein whilst also growing its teams across its offices in Glasgow, London and at Sas van Gent. The company aims to grow over one million tonnes of ABUNDA cumulatively by 2032, the equivalent of replacing 5 million cows or over 1 billion chickens, to feed a growing global population and tackle the unsustainable impact of traditional protein farming.

Read the orginal article: https://www.eu-startups.com/2023/08/glasgow-based-enough-bites-e40-million-growth-funding-to-high-scale-mycoprotein-production/

Gateways to Italy

36Brains – Considering Cross-Border M&A? We stand as your partner for ESG, Reputational and Supply Chain Due Diligence

36Brains – Considering Cross-Border M&A? We stand as your partner for ESG, Reputational and Supply Chain Due Diligence

by Partner
November 9, 2023

La Scala Law Firm – Innovative Services for Banking, Finance and Corporates

La Scala Law Firm – Innovative Services for Banking, Finance and Corporates

by Partner
October 31, 2023

Di Luccia & Partners Executive Search – Senior Management for Private Capital Funds’ participated companies

Di Luccia & Partners Executive Search – Senior Management for Private Capital Funds’ participated companies

by Partner
September 1, 2023

Sign up to our newsletter

SIGN UP

Related Posts

FRANCE

The NDC Partnership Joins the COP28 and CBD COP15 Presidencies and Nearly 30 Countries and Coalitions Advancing Integrated Action for Climate and Nature

December 9, 2023
PRIVATE DEBT

White & Case advises bookrunners on US$600 million notes issuance by Mersin International Port

December 8, 2023
BENELUX

Bunq’s Ali Niknam receives ‘Businessman of the Year’ award: Know more

December 8, 2023

ItaHub

Italy’s Supreme Court confirms: For the reimbursement of dividend tax paid by an Italian subsidiary to its UE-based parent no demonstration of actual payment is required

Italy’s Supreme Court confirms: For the reimbursement of dividend tax paid by an Italian subsidiary to its UE-based parent no demonstration of actual payment is required

October 31, 2023
Anti-money laundering, the system for reporting data and information on beneficial ownership in Italy is up and running

Anti-money laundering, the system for reporting data and information on beneficial ownership in Italy is up and running

October 27, 2023
Single Special Economic Zone, here are all details to catch new investment opportunities in Southern Italy

Single Special Economic Zone, here are all details to catch new investment opportunities in Southern Italy

October 9, 2023
Impaired loans, Valentini, Italy’s Deputy Minister of Enterprise and Made in Italy, at Banca Ifis event reassures: we have a market that works, we don’t want to upset it

Impaired loans, Valentini, Italy’s Deputy Minister of Enterprise and Made in Italy, at Banca Ifis event reassures: we have a market that works, we don’t want to upset it

September 25, 2023

Co-sponsor

Premium

Fintech, m&a on Italian-driven startups grows and platform brokerage increases. But venture capital raising is less than 200 mln euros in 32 rounds YTD. The Report of BeBeez

Fintech, m&a on Italian-driven startups grows and platform brokerage increases. But venture capital raising is less than 200 mln euros in 32 rounds YTD. The Report of BeBeez

November 29, 2023
Venture capital investments on Italian-driven startups and scaleups rise to just over 1 bn euros in 10 months. But this is still a long way from the over 2.5 bln figure in 2022

Venture capital investments on Italian-driven startups and scaleups rise to just over 1 bn euros in 10 months. But this is still a long way from the over 2.5 bln figure in 2022

November 13, 2023
Italy’s Supreme Court confirms: For the reimbursement of dividend tax paid by an Italian subsidiary to its UE-based parent no demonstration of actual payment is required

Italy’s Supreme Court confirms: For the reimbursement of dividend tax paid by an Italian subsidiary to its UE-based parent no demonstration of actual payment is required

October 31, 2023
Anti-money laundering, the system for reporting data and information on beneficial ownership in Italy is up and running

Anti-money laundering, the system for reporting data and information on beneficial ownership in Italy is up and running

October 27, 2023
Next Post

SimplicityDX named a Gartner Cool Vendor in Digital Commerce and Wins 2023 MarTech Breakthrough Awards For “Social Media”

Mysthera Therapeutics Launches to Develop First-in-Class Autoimmune Disease Therapies

EdiBeez srl

C.so Italia 22 - 20122 - Milano
C.F. | P.IVA 09375120962
Aut. Trib. Milano n. 102
del 3 aprile 2013

COUNTRY

Italy
Iberia
France
UK&Ireland
Benelux
DACH
Scandinavia&Baltics

CATEGORY

Private Equity
Venture Capital
Private Debt
Distressed Assets
Real Estate
Fintech
Green

PREMIUM

ItaHUB
Legal
Tax
Trend
Report
Insight view

WHO WE ARE

About Us
Media Partnerships
Contact

INFORMATION

Privacy Policy
Terms&Conditions
Cookie Police
No Result
View All Result
  • COUNTRY
    • ITALY
    • IBERIA
    • FRANCE
    • UK&IRELAND
    • BENELUX
    • DACH
    • SCANDINAVIA&BALTICS
  • PRIVATE EQUITY
  • VENTURE CAPITAL
  • PRIVATE DEBT
  • DISTRESSED ASSETS
  • REAL ESTATE
  • FINTECH
  • GREEN
  • PREMIUM
    • ItaHub
      • ItaHub Legal
      • ItaHub Tax
      • ItaHub Trend
    • REPORT
    • INSIGHT VIEW
Subscribe
  • Login
  • Cart

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In